Schnitzler syndrome: A review of literature, the authors' observation, and experience with the interleukin-1 inhibitor canakinumab

被引：2
|
作者：
Salugina, S. O. [1 ]
Gorodetsky, V. R. [1 ]
Fedorov, E. S. [1 ]
Lopatina, N. E. [1 ]
Evsikova, M. D. [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2017年 / 89卷 / 11期
关键词：
autoinflammatory diseases; Schnitzler syndrome; therapy; IL-1; inhibitors; canakinumab; CHRONIC URTICARIA; FOLLOW-UP; ANAKINRA; MACROGLOBULINEMIA; GAMMOPATHY; DISEASE; SAFETY;
D O I：
10.17116/terarkh20178911111-115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The paper reviews the publications dealing with Schnitzler syndrome, a rare autoinflammatory disease, and describes the authors' own clinical observation. It describes the first Russian experience in successfully using the interleukin-1 inhibitor canakinumab to treat this disease.
引用
收藏
页码：111 / 115
页数：7
相关论文
共 50 条
  • [31] SCHNITZLER SYNDROME (URTICARIA AND MACROGLOBULINEMIA) - SERUM IGM IMMUNOREACTIVITY AGAINST INTERLEUKIN-1 (IL-1) AS SHOWN BY IMMUNOBLOTTING
    DIDIERJEAN, L
    SAURAT, JH
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (03) : 393 - 393
  • [32] The Interleukin-1 Inhibitor Canakinumab for Familial Mediterranean Fever: Long-Term Beneficial Effect in a Cohort of 13 Patients
    Laskari, Katerina
    Boura, Panagiota
    Dalekos, George N.
    Garyfallos, Alexandros
    Karokis, Dimitrios
    Pikazis, Dimitrios
    Settas, Loukas
    Skarantavos, Grigoris
    Tsitsami, Elena
    Sfikakis, Petros P.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [33] PURIFICATION OF A SPECIFIC INTERLEUKIN-1 INHIBITOR
    SECKINGER, P
    DAYER, JM
    ISAAZ, S
    SHAW, A
    MAZZEI, G
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (05) : 543 - 543
  • [34] NEUTROPHIL PRODUCTION OF AN INTERLEUKIN-1 INHIBITOR
    TIKU, K
    SKOSEY, JL
    TIKU, ML
    JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 37 (06) : 747 - 747
  • [35] CHARACTERIZATION OF A HUMAN INTERLEUKIN-1 INHIBITOR
    LIAO, ZH
    HAIMOVITZ, A
    CHEN, YY
    CHAN, J
    ROSENSTREICH, DL
    JOURNAL OF IMMUNOLOGY, 1985, 134 (06): : 3882 - 3886
  • [36] CHARACTERIZATION OF A HUMAN INTERLEUKIN-1 INHIBITOR
    BARAK, V
    BRAUN, S
    YANAI, P
    HALPERIN, M
    TREVES, AJ
    LYMPHOKINE RESEARCH, 1987, 6 (01): : U70 - U70
  • [37] THE INTERLEUKIN-1 INHIBITOR CANAKINUMAB FOR FAMILIAL MEDITERRANEAN FEVER: LONG-TERM BENEFICIAL EFFECT IN A COHORT OF 14 PATIENTS
    Laskari, K.
    Boura, P.
    Dalekos, G. N.
    Garyfallos, A.
    Karokis, D.
    Pikazis, D.
    Settas, L.
    Skarantavos, G.
    Tsitsami, E.
    Sfikakis, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 618 - 619
  • [38] Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome
    Hodl, Isabel
    Bosch, Philipp
    Dreo, Barbara
    Stradner, Martin H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [39] Regulation of interleukin-1β and interleukin-1β inhibitor release by human airway epithelial cells
    Yang, Y
    Bin, W
    Aksoy, MO
    Kelsen, SG
    EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (03) : 360 - 366
  • [40] Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
    Ridker, Paul M.
    MacFadyen, Jean G.
    Glynn, Robert J.
    Koenig, Wolfgang
    Libby, Peter
    Everett, Brendan M.
    Lefkowitz, Martin
    Thuren, Tom
    Cornel, Jan H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (21) : 2405 - 2414
12345